Sarepta Therapeutics, Inc.
SRPT News Today: Stay Updated with the Latest Sarepta Therapeutics, Inc. News in Real Time
Find SRPT news now at Meyka AI. Stay informed with the latest Sarepta Therapeutics, Inc. stocks updates, including price news, market analysis, and expert insights.
MIRM Mirum Pharmaceuticals, Inc. Feb 26 2026 Leerink Maintains Outperform
MIRM analyst rating update: three firms maintained Outperform on Feb 26, 2026; Leerink cut PT to $118
Raymond James Maintains Outperform on Acadia Healthcare (ACHC) Feb 26 2026
Raymond James maintained Outperform on ACHC Feb 26 2026; our take on the ACHC analyst rating and investor implications
MRK Holdings (9980.T JPX) jumps 32.26% intraday Feb 27, 2026: watch earnings signal
9980.T stock jumps 32% intraday on Feb 27, 2026; read intraday drivers, Meyka AI grade and a JPY forecast
NVV1.F Novavax, Inc. (XETRA) up 15.65% pre-market 27 Feb 2026: earnings catalyst
NVV1.F stock jumps 15.65% pre-market on 27 Feb 2026 as earnings news and volume push price to €9.46
VTI.CN stock down 66.67% to C$0.005 on CNQ 27 Feb 2026: risk and model outlook
VTI.CN stock falls 66.67% to C$0.005 on CNQ. Quick analysis, Meyka AI forecast and downside risk for investors.
100,000-share volume spike 27 Feb 2026: AURT Attune RTD (PNK) liquidity check
AURT stock sees a 100,000-share volume spike on 27 Feb 2026; quick liquidity and risk assessment for traders
William Blair Upgrades Lantheus Holdings (LNTH) to Outperform Feb 26, 2026
William Blair upgrades Lantheus Holdings; read impacts and context of the LNTH analyst rating
BTIG Maintains Buy on Delcath Systems (DCTH) Feb 2026, PT Cut to $19
BTIG maintains Buy on Delcath Systems; PT cut to $19. DCTH analyst rating note and investor implications
KYMR: Kymera Therapeutics Maintained Outperform by RBC Capital Feb 26 2026
RBC Capital maintained KYMR analyst rating at Outperform and raised PT to $108 on Feb 26 2026; implications and Meyka AI grade B+